Keycorp SEC Filings

KeyCorp reported it issued a press release announcing financial results for the three- and nine-month periods ended September 30, 2025, and posted a third‑quarter 2025 supplemental information package. Both materials were furnished as Exhibits 99.1 and 99.2.

The company also filed its Consolidated Balance Sheets and Consolidated Statements of Income as Exhibit 99.3, which are deemed “filed” under the Exchange Act and may be incorporated by reference in Securities Act filings. The report is dated October 16, 2025.

KeyCorp (KEY) reported an insider transaction by a director. On 10/01/2025, deferred share units were distributed into common stock under the company’s deferred compensation arrangements, resulting in acquisitions of 1,493 and 1,363 common shares. Following these transactions, the director beneficially owned 76,126 common shares directly. A portion of the total includes approximately 146 common shares acquired via dividend reinvestments in September 2025.

The filing also shows continuing derivative balances of deferred share units, which are economically equivalent to common shares: 12,089 deferred shares (including approximately 147 dividend-equivalent deferred shares accrued in September 2025) and 178,474 deferred shares (including approximately 1,936 dividend-equivalent deferred shares accrued in September 2025). Certain deferred shares are scheduled to distribute in ten quarterly installments beginning on July 1, 2025.

Todd J. Vasos, a director of KeyCorp (KEY), reported transactions dated 09/30/2025. The filing shows a disposition of 35,255 common shares (non-derivative) and the acquisition of 1,738 deferred shares under the KeyCorp Deferred Share Plan converted from deferred director fees at an effective price of $18.69 per share. The report states that approximately 658 dividend-equivalent deferred shares were included in September 2025. Payment of deferred shares is scheduled for the earlier of January 1, 2027 or the participant's death. The Form 4 was signed by a POA, Adam J. Larkins, on 10/02/2025.

Devina A. Rankin, a KeyCorp (KEY) director, reported transactions on 09/30/2025 showing a sale of 13,430 common shares and the acquisition of 1,605 deferred shares under the company’s Amended and Restated Directors' Deferred Share Sub-Plan. The deferred shares represent fees directors elected to defer and are the economic equivalent of common shares; they are payable the earlier of January 1, 2031 or the participant’s death. The filing reports total beneficial ownership of 77,121 common shares following the transactions and notes approximately 813 dividend-equivalent deferred shares accrued in September 2025. The Form 4 was signed by a power of attorney on 10/02/2025.

Christopher M. Gorman, Chairman and CEO of KeyCorp (KEY), reported changes to his beneficial ownership on Form 4 filed for transactions dated 09/10/2025. Upon termination of a grantor retained annuity trust (GRAT) on September 9, 2025, 66,645 shares of KeyCorp common stock were transferred to the reporting person's children and 60,000 shares from that trust were returned to Gorman and are reported as directly owned. The filing shows Gorman directly owns 679,925 shares (including ~31 shares acquired under KeyCorp's discounted stock purchase plan in August 2025) and reports additional indirect holdings of 200,000 and 250,000 shares held in other GRATs, plus 5,235 shares in a 401(k) plan. The Form 4 was signed by a power of attorney on 09/11/2025.

KeyCorp (KEY) insider Andrew J. Paine III reported option exercise and an offsetting sale on 09/09/2025. The filing shows an option to buy 44,953 common shares with a $10.49 exercise price was exercised and recorded as an acquisition. The same number of shares, 44,953, were sold at $19.29 on the same date. After these transactions the reporting person directly beneficially owned 245,044 shares and also reported indirect holdings: 108,746 shares via a GRAT, 445 via Paine Investments LP, 4,265 by spouse, and 26,176 in a 401(k) plan.

Form 144 filing for KeyCorp (KEY) shows a notice of proposed sale of 44,955 common shares through Fidelity Brokerage Services with an aggregate market value of $867,143.45. The filing reports the shares represent a small fraction of total outstanding common shares of 1,096,515,839 and lists an approximate sale date of 09/09/2025 on the NYSE.

The acquisition details state two de minimis restricted-share vests of 1 share each in March 2016 recorded as compensation, and the remaining 44,953 shares are tied to an option granted 02/15/2016 with a reported acquisition/transaction date of 09/09/2025 and payment in cash. No other sales in the past three months were reported and no additional financial results or operational disclosures are included.